rs1553361274
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5
The NM_000251.3(MSH2):c.1355A>T(p.Glu452Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000251.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.E452V variant (also known as c.1355A>T), located in coding exon 8 of the MSH2 gene, results from an A to T substitution at nucleotide position 1355. The glutamic acid at codon 452 is replaced by valine, an amino acid with dissimilar properties. Splicing assays demonstrated that this variant results in the activation of the cryptic donor site led to a 33 bp in-frame deletion resulting in loss of the terminal 11 amino acids of exon 8 (Ambry internal data). This alteration has also been reported as a variant of uncertain significance in a 38 year old female with proximal colon cancer and a family history meeting Amsterdam criteria (Chubb D et al, J. Clin. Oncol. 2015 Feb; 33(5):426-32). This alteration is located in the MutS DNA binding domain of the MSH2 protein. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site and will result in the creation or strengthening of a novel splice donor site. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 452 of the MSH2 protein (p.Glu452Val). RNA analysis indicates that this missense change induces altered splicing and likely results in the loss of 11 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MSH2-related conditions. ClinVar contains an entry for this variant (Variation ID: 483677). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 33357406) indicates that this missense variant is not expected to disrupt MSH2 function with a negative predictive value of 80%. Studies have shown that this missense change results in the activation of a cryptic splice site in exon 8 (Invitae). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at